Cell-surface expression of Hsp70 on hematopoietic cancer cells after inhibition of HDAC activity

Journal of Leukocyte Biology

Volumn 86, Issue 4, 2009, Pages 923-932

  Jensen, Helle ^a   Andresen, Lars ^a   Hansen, Karen Aagaard ^a   Skov, Søren ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

HDAC inhibitor; Stress molecules; Tumor immunology

Indexed keywords

CALCIUM; HEAT SHOCK PROTEIN 70; HISTONE DEACETYLASE; HISTONE DEACETYLASE INHIBITOR; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE; TRANSCRIPTION FACTOR SP1;

ANTIGEN RECOGNITION; APOPTOSIS; ARTICLE; CALCIUM CELL LEVEL; CANCER CELL; CD4+ T LYMPHOCYTE; CELL STRESS; CELL SURFACE; ENDOPLASMIC RETICULUM; ENZYME ACTIVITY; GOLGI COMPLEX; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; LYMPHOCYTE ACTIVATION; LYSOSOME; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANNEXIN A5; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; CAMPTOTHECIN; CD4-POSITIVE T-LYMPHOCYTES; ENZYME INHIBITORS; ETOPOSIDE; GENE EXPRESSION REGULATION, NEOPLASTIC; HEMATOPOIETIC STEM CELLS; HISTONE DEACETYLASES; HSP70 HEAT-SHOCK PROTEINS; HUMANS; JURKAT CELLS; K562 CELLS; NEOPLASM PROTEINS; NEOPLASTIC STEM CELLS; SP1 TRANSCRIPTION FACTOR;

EID: 70349644765     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.0209056     Document Type: Article

References (35)

1. Schmitt, E., Gehrmann, M., Brunet, M., Multhoff, G., Garrido, C. (2007) Intracellular and extracellular functions of heat shock proteins: repercussions in cancer therapy. J. Leukoc. Biol. 81, 15-27. (Pubitemid 46021247)
2. Sherman, M., Multhoff, G. (2007) Heat shock proteins in cancer. Ann. N. Y. Acad. Sci. 1113, 192-201.
3. Gastpar, R., Gehrmann, M., Bausero, M. A., Asea, A., Gross, C., Schroeder, J. A., Multhoff, G. (2005) Heat shock protein 70 surface-positive tumor exosomes stimulate migratory and cytolytic activity of natural killer cells. Cancer Res. 65, 5238-5247. (Pubitemid 40827334)
4. Gehrmann, M., Schmetzer, H., Eissner, G., Haferlach, T., Hiddemann, W., Multhoff, G. (2003) Membrane-bound heat shock protein 70 (Hsp70) in acute myeloid leukemia: a tumor specific recognition structure for the cytolytic activity of autologous NK cells. Haematologica 88, 474-476. (Pubitemid 36547137)
5. Asea, A., Kraeft, S. K., Kurt-Jones, E. A., Stevenson, M. A., Chen, L. B., Finberg, R. W., Koo, G. C., Calderwood, S. K. (2000) HSP70 stimulates cytokine production through a CD14-dependant pathway, demonstrating its dual role as a chaperone and cytokine. Nat. Med. 6, 435-442. (Pubitemid 30208161)
6. Lehner, T., Wang, Y., Whittall, T., McGowan, E., Kelly, C. G., Singh, M. (2004) Functional domains of HSP70 stimulate generation of cytokines and chemokines, maturation of dendritic cells and adjuvanticity. Biochem. Soc. Trans. 32, 629-632. (Pubitemid 39120401)
7. Shin, B. K., Wang, H., Yim, A. M., Le, N. F., Brichory, F., Jang, J. H., Zhao, R., Puravs, E., Tra, J., Michael, C. W., Misek, D. E., Hanash, S. M. (2003) Global profiling of the cell surface proteome of cancer cells uncovers an abundance of proteins with chaperone function. J. Biol. Chem. 278, 7607-7616. (Pubitemid 36800769)
8. Botzler, C., Ellwart, J., Gunther, W., Eissner, G., Multhoff, G. (1999) Synergistic effects of heat and ET-18-OCH3 on membrane expression of hsp70 and lysis of leukemic K562 cells. Exp. Hematol. 27, 470-478. (Pubitemid 29125055)
9. Gehrmann, M., Pfister, K., Hutzler, P., Gastpar, R., Margulis, B., Multhoff, G. (2002) Effects of antineoplastic agents on cytoplasmic and membrane-bound heat shock protein 70 (Hsp70) levels. Biol. Chem. 383, 1715-1725. (Pubitemid 36033085)
10. Gehrmann, M., Brunner, M., Pfister, K., Reichle, A., Kremmer, E., Multhoff, G. (2004) Differential up-regulation of cytosolic and membrane-bound heat shock protein 70 in tumor cells by anti-inflammatory drugs. Clin. Cancer Res. 10, 3354-3364. (Pubitemid 38685440)
11. Mambula, S. S., Calderwood, S. K. (2006) Heat shock protein 70 is secreted from tumor cells by a nonclassical pathway involving lysosomal endosomes. J. Immunol. 177, 7849-7857.
12. Gehrmann, M., Liebisch, G., Schmitz, G., Anderson, R., Steinem, C., De, M. A., Pockley, G., Multhoff, G. (2008) Tumor-specific Hsp70 plasma membrane localization is enabled by the glycosphingolipid Gb3. PLoS ONE 3, e1925. (Pubitemid 351984120)
13. Secrist, J. P., Zhou, X., Richon, V. M. (2003) HDAC inhibitors for the treatment of cancer. Curr. Opin. Investig. Drugs 4, 1422-1427.
14. Yoshida, M., Matsuyama, A., Komatsu, Y., Nishino, N. (2003) From discovery to the coming generation of histone deacetylase inhibitors. Curr. Med. Chem. 10, 2351-2358. (Pubitemid 37236392)
15. Andresen, L., Jensen, H., Pedersen, M. T., Hansen, K. A., Skov, S. (2007) Molecular regulation of MHC class I chain-related protein A expression after HDAC-inhibitor treatment of Jurkat T cells. J. Immunol. 179, 8235-8242.
16. Bauer, S., Groh, V., Wu, J., Steinle, A., Phillips, J. H., Lanier, L. L., Spies, T. (1999) Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. Science 285, 727-729. (Pubitemid 129505074)
17. Groh, V., Bruhl, A., El-Gabalawy, H., Nelson, J. L., Spies, T. (2003) Stimulation of T cell autoreactivity by anomalous expression of NKG2D and its MIC ligands in rheumatoid arthritis. Proc. Natl. Acad. Sci. USA 100, 9452-9457. (Pubitemid 37033949)
18. Groh, V., Smythe, K., Dai, Z., Spies, T. (2006) Fas-ligand-mediated paracrine T cell regulation by the receptor NKG2D in tumor immunity. Nat. Immunol. 7, 755-762. (Pubitemid 43905875)
19. Vivier, E., Tomasello, E., Paul, P. (2002) Lymphocyte activation via NKG2D: towards a new paradigm in immune recognition? Curr. Opin. Immunol. 14, 306-311. (Pubitemid 34327971)
20. Skov, S., Pedersen, M. T., Andresen, L., Straten, P. T., Woetmann, A., Odum, N. (2005) Cancer cells become susceptible to natural killer cell killing after exposure to histone deacetylase inhibitors due to glycogen synthase kinase-3-dependent expression of MHC class I-related chain A and B. Cancer Res. 65, 11136-11145. (Pubitemid 41713385)
21. Herst, P. M., Petersen, T., Jerram, P., Baty, J., Berridge, M. V. (2007) The antiproliferative effects of phenoxodiol are associated with inhibition of plasma membrane electron transport in tumor cell lines and primary immune cells. Biochem. Pharmacol. 74, 1587-1595. (Pubitemid 47614971)
22. Moreira, J. M., Scheipers, P., Sørensen, P. (2003) The histone deacetylase inhibitor Trichostatin A modulates CD4+ T cell responses. BMC Cancer 3, 30. (Pubitemid 38846518)
23. Ryu, H., Lee, J., Olofsson, B. A., Mwidau, A., Dedeoglu, A., Escudero, M., Flemington, E., Azizkhan-Clifford, J., Ferrante, R. J., Ratan, R. R. (2003) Histone deacetylase inhibitors prevent oxidative neuronal death independent of expanded polyglutamine repeats via an Sp1-dependent pathway. Proc. Natl. Acad. Sci. USA 100, 4281-4286. (Pubitemid 36418194)
24. Xiao, H., Hasegawa, T., Isobe, K. (1999) Both Sp1 and Sp3 are responsible for p21waf1 promoter activity induced by histone deacetylase inhibitor in NIH3T3 cells. J. Cell. Biochem. 73, 291-302. (Pubitemid 29198004)
25. Herst, P. M., Berridge, M. V. (2006) Plasma membrane electron transport: a new target for cancer drug development. Curr. Mol. Med. 6, 895-904.
26. Voorzanger-Rousselot, N., Garnero, P. (2007) Biochemical markers in oncology. Part I: molecular basis. Part II: clinical uses. Cancer Treat. Rev. 33, 230-283. (Pubitemid 46767942)
27. Shankar, S., Srivastava, R. K. (2008) Histone deacetylase inhibitors: mechanisms and clinical significance in cancer: HDAC inhibitor-induced apoptosis. Adv. Exp. Med. Biol. 615, 261-298.
28. Schmudde, M., Braun, A., Pende, D., Sonnemann, J., Klier, U., Beck, J. F., Moretta, L., Broker, B. M. (2008) Histone deacetylase inhibitors sensitize tumor cells for cytotoxic effects of natural killer cells. Cancer Lett. 272, 110-121.
29. Sapozhnikov, A. M., Gusarova, G. A., Ponomarev, E. D., Telford, W. G. (2002) Translocation of cytoplasmic HSP70 onto the surface of EL-4 cells during apoptosis. Cell Prolif. 35, 193-206.
30. Green, D. R., Ferguson, T., Zitvogel, L., Kroemer, G. (2009) Immunogenic and tolerogenic cell death. Nat. Rev. Immunol. 9, 353-363.
31. Woehlecke, H., Pohl, A., Alder-Baerens, N., Lage, H., Herrmann, A. (2003) Enhanced exposure of phosphatidylserine in human gastric carcinoma cells overexpressing the half-size ABC transporter BCRP (ABCG2). Biochem. J. 376, 489-495. (Pubitemid 38010534)
32. Pohl, A., Lage, H., Muller, P., Pomorski, T., Herrmann, A. (2002) Transport of phosphatidylserine via MDR1 (multidrug resistance 1) P-glycoprotein in a human gastric carcinoma cell line. Biochem. J. 365, 259-268. (Pubitemid 34756160)
33. Arispe, N., Doh, M., Simakova, O., Kurganov, B., De, M. A. (2004) Hsc70 and Hsp70 interact with phosphatidylserine on the surface of PC12 cells resulting in a decrease of viability. FASEB J. 18, 1636-1645. (Pubitemid 39463703)
34. Kantari, C., Pederzoli-Ribeil, M., Amir-Moazami, O., Gausson-Dorey, V., Moura, I. C., Lecomte, M. C., Benhamou, M., Witko-Sarsat, V. (2007) Proteinase 3, the Wegener autoantigen, is externalized during neutrophil apoptosis: evidence for a functional association with phospholipid scramblase 1 and interference with macrophage phagocytosis. Blood 110, 4086-4095. (Pubitemid 350248466)
35. Gehrmann, M., Schonberger, J., Zilch, T., Rossbacher, L., Thonigs, G., Eilles, C., Multhoff, G. (2005) Retinoid- and sodium-butyrate-induced decrease in heat shock protein 70 membrane-positive tumor cells is associated with reduced sensitivity to natural killer cell lysis, growth delay, and altered growth morphology. Cell Stress Chaperones 10, 136-146. (Pubitemid 40942474)